ClinicalTrials.govpublic full text
An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells
multiple myeloma, hematopoietic stem cell transplantation, tumour cell mobilization, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 812479
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.